Dynavax Technologies | Creditori Commerciali





Creditori Commerciali Cambiamento Data
AbbVie USD 32.25B 1.2B 2025-06
Adma Biologics USD 24.02M 5.75M 2025-09
Agenus USD 85.29M 10.89M 2025-09
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Dynavax Technologies USD 3.95M 1.25M 2025-09
Gilead Sciences USD 808M 226M 2025-09
Glaxosmithkline GBP 21.07B 7.42B 2025-09
Merck USD 4.15B 102M 2025-09
Minerva Neurosciences USD 945K 48K 2025-09
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Neurocrine Biosciences USD 119.9M 15.3M 2025-09
Novartis USD 4.56B 49M 2025-09
Pfizer USD 5.02B 142M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
TG Therapeutics USD 61.64M 72.38M 2025-09
Vertex Pharmaceuticals USD 4.03B 320.8M 2025-09


Dynavax Technologies Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.